Diagnostics company Qiagen (QIA.DE) is drawing early takeover interest from buyout firms, including EQT AB (EQTAB.ST), Advent and KKR (KKR.N), with potential offers from some suitors reaching at least $50 per Qiagen share, Bloomberg News reported. No final decisions have been made and the discussions may not result in a deal, the report said, citing people familiar with the matter. It added that the firm could attract more buyout firms, as well as strategic players. Last year, Qiagen announced that Thierry Bernard would step down as chief executive officer and managing director.
Read the full article: EQT, Advent, KKR Explore Takeover of Diagnostics Firm Qiagen //
Source: https://www.reuters.com/business/qiagen-draws-early-takeover-interest-eqt-advent-kkr-bloomberg-news-reports-2026-07-09/